Small cell lung cancer, or SCLC, is fraught with challenges. Patients are often diagnosed late so outcomes are poor; therapeutic advances have stalled due to lackluster funding and the disease, ...

Fred Hutch cancer metabolism expert Dr. Lucas Sullivan discovered that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death, a ...

SEATTLE – March 4, 2026 – Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. March is the awareness month for colorectal cancer and multiple ...

Fred Hutch Esophageal Cancer Specialty Clinic Our esophageal cancer specialists work closely with you, your family and each other to get you back to health. At Fred Hutch, we provide all standard ...

Hutchinson Institute for Cancer Outcomes Research (HICOR) is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the ...

The Summer Undergraduate Research Program (SURP) is an intensive, nine-week internship for undergraduates entering the summer before their final year, semester, or quarter of study. It's designed to ...

Michael Haffner, MD, PhD, and Kevin Cheung, MD, have recently been awarded multi-year research grants from the V Foundation for Cancer Research.

The CSRN is a multi-center effort, funded by the National Cancer Institute, and is the first large-scale network to focus on cancer screening. Fred Hutch Cancer Center serves as the coordinating and ...

Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...

“She was only 61 and very healthy,” said Allan Knight of his mother Judy, who was diagnosed and died of pancreatic cancer in 2007. “I did one search and the survival rates were in the single digits. I ...

Bisphosphonates are popular bone-targeting drugs. Older people take them to prevent and treat osteoporosis. Breast cancer patients, particularly those with metastatic disease, take them to prevent and ...

Dietary supplements are wildly popular, but large clinical trials and other research by Fred Hutch Cancer Center scientists show that many common dietary supplements offer little proven benefit for ...